EUVIMEDOpdag EUVIMED
Editorial

Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?

W Bryan Burnette iD

Muscle & Nerve · 2024

DOI: 10.1002/mus.28107 ↗

At a glance

Editorial in Muscle & Nerve, 2024. Written by W Bryan Burnette. Institution: Vanderbilt University Medical Center, Nashville, Tennessee, USA. Major MEDLINE topics: Muscular Dystrophy, Duchenne. 9 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Subjects

MeSH terms (MEDLINE)

Muscular Dystrophy, DuchenneHumansMorpholinosMaleChildSteroids

Substances

eteplirsenMorpholinosSteroids

Authors and institutions

  • Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID profiles: W Bryan Burnette

Cite

APA

Burnette, W. B. (2024). Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. https://doi.org/10.1002/mus.28107

Vancouver

Burnette WB. Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?. Muscle & Nerve. 2024. doi:10.1002/mus.28107

BibTeX
@article{Burnette2024,
  author = {Burnette, W Bryan},
  title = {Survival in eteplirsen‐treated Duchenne Muscular Dystrophy patients: Are there benefits beyond steroids?},
  journal = {Muscle & Nerve},
  year = {2024},
  doi = {10.1002/mus.28107}
}
Start for free →